The global antiseptic and disinfectant market size is anticipated to reach USD 63.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.8% from 2024 to 2030. Key factors driving the market expansion include technological advancements in antiseptics and disinfectants along with increasing use of endoscope reprocessors and surgical units. The current COVID-19 outbreak is expected to have a substantial impact on the market. The pandemic has resulted in a significant surge in demand for emergency supplies, hospital equipment, medicines, and medical disposables. According to Eurostat in 2020, extra-EU exports and imports of COVID-19 related products increased by 5.5 % and 10.4 % respectively, compared to 2019.
Additionally, EU extra- imports of protective oxygen and garments equipment recorded the highest increase (respectively by 38.7% and 40.3 % compared with 2019) amongst COVID-19 related products, followed by sterilization products (19.1 %) and. diagnostic equipment (19.2 %). However, the highest increases for EU- extra- exports were recorded for diagnostic testing equipment (14.9%), and sterilization products (16.0 %). As a result, market growth is expected to accelerate in the near future. Furthermore, the global market for antiseptics and disinfectants is consolidating due to the rising popularity of medical equipment along with the increased research collaboration and agreements between diverse manufacturers. For instance, in June 2021, Bactiguard and Schülke & Mayr GmbH, a German company, agreed to distribute Bactiguard's wound care solutions exclusively to German hospitals. The agreement allows schülke to add Bactiguard's hypochlorous acid-based portfolio to its existing antiseptic and wound-care product line which will, in turn, push the market scale during the study period.
Request a free sample copy or view report summary: Antiseptics And Disinfectants Market Report
In terms of revenue, the quaternary ammonium compounds held the largest share of around 31.4% in 2023, owing to the rising incidence of healthcare-associated infections and the increasing number of hospitals across the globe
The enzymatic cleaners segment is expected to witness the fastest CAGR of 10.5% over the forecast period. The growth of this segment can be attributed to the increasing number of hospitals in developing countries
The hospital segment is expected to witness the fastest growth rate of 10.6% over the forecast period. The increasing number of hospitals in developing countries is expected to propel segment growth
In terms of revenue, the B2B segment held the largest share owing to the rising end-users opting for this sales channel across the globe
In Asia Pacific, the market is expected to witness the fastest CAGR of 11.5% over the forecast period, owing to the rising prevalence of cardiovascular, neurology, and urology disorders
Grand View Research has segmented the global antiseptic and disinfectant market report based on type, product, sales channel, end-use, and region:
Antiseptic & Disinfectant Type Outlook (Revenue, USD Million, 2018 - 2030)
Quaternary Ammonium Compounds
Chlorine Compounds
Alcohols & Aldehyde Products
Enzyme
Others
Antiseptic & Disinfectant Product Outlook (Revenue, USD Million, 2018 - 2030)
Enzymatic Cleaners
Medical Device Disinfectants
Surface Disinfectants
Antiseptic & Disinfectant Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
B2B
FMCG
Antiseptic & Disinfectant End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Others
Antiseptic & Disinfectant Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Antiseptic And Disinfectant Market
3M
Reckitt Benckiser
Steris Plc
Kimberly-Clark Corporation
Bio-Cide International, Inc.
Cardinal Health
BD
Johnson & Johnson
"The quality of research they have done for us has been excellent..."